| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23155-742-05 | 23155-742 | HUMAN PRESCRIPTION DRUG | Theophylline | Theophylline | TABLET, EXTENDED RELEASE | ORAL | 20220512 | N/A | ANDA | ANDA081236 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | THEOPHYLLINE ANHYDROUS | 450 mg/1 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (23155-742-05) |
| 23155-742-01 | 23155-742 | HUMAN PRESCRIPTION DRUG | Theophylline | Theophylline | TABLET, EXTENDED RELEASE | ORAL | 20220512 | N/A | ANDA | ANDA081236 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | THEOPHYLLINE ANHYDROUS | 450 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (23155-742-01) |